European Archives - Page 17 of 1143 - European Medical Journal

Candida Infection in NICU/PICU: Prevalence, Associated Risk Factors, and Outcomes

Invasive Candida infections represent a significant healthcare concern, particularly in the vulnerable paediatric population. Candida…

EMJ Microbiology & Infectious Diseases 6.1 2025

Inside this issue, you will find a variety of content, including our comprehensive review of the ESCMID Global Congress 2025, alongside exclusive interviews with key opinion leaders…

Leveraging Genetic Insights to Predict Collateral Sensitivity and Synergism for Effective Multidrug Therapies

The ability to design multidrug treatment strategies that manage, reduce or ideally prevent drug resistance in microbial populations are…

Polyarticular Septic Arthritis and Osteomyelitis Due to Burkholderia Cepacia in an Immunocompetent Patient

The Burkholderia cepacia complex (BCC) is a group of at least 20 distinct bacterial species within the Burkholderia genus, including…

New Frontiers in Antimicrobial Stewardship

AT the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress 2025, Karin Thursky, Director of the National Centre for Antimicrobial Stewardship…

Epidermicin NI01 Has Potent Efficacy in MRSA Wound Infection Model and Low Allergic Reaction Liabilities

Over 10% of antibiotic prescriptions are for skin infections.1,2 New therapeutic approaches are required, and new modalities may be…

Tackling Tuberculosis: The Current Landscape and Future Directions

The presentation by Guy Thwaites, Director of the Oxford University Clinical Research Unit (OUCRU), Ho Chi Minh City, Vietnam, focused on the current state of tuberculosis…

Antibiotics with Anti-Anaerobe Activity Promote Enteric Pathobionts in ICU Patients

Infectious complications in those admitted to the ICU are a major contributor to mortality. Such nosocomial infections have been…

Dolutegravir and Lamivudine vs. Efavirenz-Based Therapy for Patients with HIV and Tuberculosis

This study evaluated the efficacy and safety of a dual therapy regimen comprising double-dose dolutegravir plus lamivudine in treating…

World-First Gonorrhoea Vaccine to Launch in England

England is set to become the first country in the world to roll out a national vaccination programme against gonorrhoea, aiming to curb record-high infection rates and growing antibiotic resistance.